ErbB2:EGFR ratio is a critical predictor of a mitogenic response to EGF in a prostate cancer model - potential implications for the use of anti-ErbB2 or dual tyrosine kinase inhibitors

SS El-Sheikh; J Domin; P Abel; G Stamp; El-Nasir Lalani

doi:10.1593/neo.04379

ErbB2:EGFR ratio is a critical predictor of a mitogenic response to EGF in a prostate cancer model - potential implications for the use of anti-ErbB2 or dual tyrosine kinase inhibitors

SS El-Sheikh
, J Domin
, P Abel
, G Stamp
, El-Nasir Lalani

Research output: Contribution to journal › Article

73 Citations (Scopus)

Original language	English
Pages (from-to)	846-853
Number of pages	8
Journal	Neoplasia
Volume	6
DOIs	https://doi.org/10.1593/neo.04379
Publication status	Published - 1 Nov 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1593/neo.04379

Cite this

@article{5f17afbb6afa4a1b916ffdb99aaffedc,

title = "ErbB2:EGFR ratio is a critical predictor of a mitogenic response to EGF in a prostate cancer model - potential implications for the use of anti-ErbB2 or dual tyrosine kinase inhibitors",

author = "SS El-Sheikh and J Domin and P Abel and G Stamp and El-Nasir Lalani",

year = "2004",

month = nov,

day = "1",

doi = "10.1593/neo.04379",

language = "English",

volume = "6",

pages = "846--853",

journal = "Neoplasia",

issn = "1476-5586",

publisher = "Elsevier",

}

TY - JOUR

T1 - ErbB2:EGFR ratio is a critical predictor of a mitogenic response to EGF in a prostate cancer model - potential implications for the use of anti-ErbB2 or dual tyrosine kinase inhibitors

AU - El-Sheikh, SS

AU - Domin, J

AU - Abel, P

AU - Stamp, G

AU - Lalani, El-Nasir

PY - 2004/11/1

Y1 - 2004/11/1

UR - https://www.scopus.com/pages/publications/11144292081

U2 - 10.1593/neo.04379

DO - 10.1593/neo.04379

M3 - Article

C2 - 15720812

SN - 1476-5586

VL - 6

SP - 846

EP - 853

JO - Neoplasia

JF - Neoplasia

ER -